Telix Pharmaceuticals Limited Postemployment Benefit Expense In Profit Or Loss
Telix Pharmaceuticals Limited (TLPPF) reported Postemployment Benefit Expense In Profit Or Loss of $3.54 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-20.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:PostemploymentBenefitExpenseInProfitOrLoss · last filed 2026-02-20
AUD
| Period end | Postemployment Benefit Expense In Profit Or Loss 12 month |
|---|---|
| 2024-12-31 | 2.60M AUD 20-F · filed 2025-02-24 |
| 2023-12-31 | 1.80M AUD 20-F · filed 2025-02-24 |
| 2022-12-31 | 1.27M AUD 20-F · filed 2025-02-24 |
USD
| Period end | Postemployment Benefit Expense In Profit Or Loss 12 month |
|---|---|
| 2025-12-31 | $3.54M 20-F · filed 2026-02-20 |
| 2024-12-31 | $1.71M 20-F · filed 2026-02-20 |
| 2023-12-31 | $1.24M 20-F · filed 2026-02-20 |